Daiwa Securities Group Inc. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 195 filers reported holding ANI PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$40.0%700.0%0.00%
Q2 2023$4
+33.3%
700.0%0.00%
Q1 2023$30.0%700.0%0.00%
Q4 2022$3
-99.7%
70
+159.3%
0.00%
Q3 2021$1,0000.0%270.0%0.00%
Q2 2021$1,0000.0%270.0%0.00%
Q1 2021$1,0000.0%270.0%0.00%
Q4 2020$1,000
-50.0%
27
-60.3%
0.00%
Q3 2020$2,000
-33.3%
680.0%0.00%
Q2 2020$3,0000.0%680.0%0.00%
Q1 2020$3,000
-25.0%
680.0%0.00%
Q4 2019$4,000
-33.3%
68
-10.5%
0.00%
Q3 2019$6,0000.0%760.0%0.00%
Q2 2019$6,000
+20.0%
76
+18.8%
0.00%
Q1 2019$5,000
+66.7%
640.0%0.00%
Q4 2018$3,000
-25.0%
640.0%0.00%
Q3 2018$4,0000.0%640.0%0.00%
Q2 2018$4,0000.0%640.0%0.00%
Q1 2018$4,000640.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders